Cleared Traditional

K200942 - Well-Life Garment Electrodes (GM Series)

K200942 is the FDA 510(k) clearance for Well-Life Garment Electrodes (GM Series) by Well-Life Healthcare Limited. It is a Class 2 Neurology device (product code GXY) cleared through the Traditional 510(k) pathway after a 419-day FDA review.

K200942 · Well-Life Healthcare Limited · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2021
Decision
419d
Days
Class 2
Risk

K200942 is an FDA 510(k) clearance for the Well-Life Garment Electrodes (GM Series). Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Well-Life Healthcare Limited (New Taipei City, TW). The FDA issued a Cleared decision on June 1, 2021 after a review of 419 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Neurology submissions.

View all Well-Life Healthcare Limited devices

Submission Details

510(k) Number K200942 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 2020
Decision Date June 01, 2021
Days to Decision 419 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
271d slower than avg
Panel avg: 148d · This submission: 419d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 141
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K200942.
Metallic Fabric Electrodes
K202636 · Guangzhou Xinbo Electronic Co., Ltd. · Aug 2021
Electrode Market Disposable Surface Electrodes
K211839 · Electrode Market Co., Ltd. · Jul 2021
BioWave BioWraps
K203158 · Biowave Corporation · Jul 2021
NeuroCap (Model DEC22)
K202913 · Memory MD, Inc. · Mar 2021
MR Conditional Sticky Pad Electrode
K203079 · Rhythmlink International, LLC · Feb 2021
Jiajian Self-Adhesive Electrode
K192568 · Wuxi Jiajian Medical Instrument Co., Ltd. · Feb 2021